Trials (University Cancer Center Frankfurt): Revision history

14 December 2025

• curprev 20:3920:39, 14 December 2025‎ Francine talk contribs‎ 20,656 bytes +180‎ No edit summary undo

6 December 2025

• curprev 12:4212:42, 6 December 2025‎ Lucas talk contribs‎ m 20,476 bytes +1,701‎ Update categories. undo

3 December 2025

• curprev 03:2803:28, 3 December 2025‎ Larysse talk contribs‎ 18,775 bytes +49‎ No edit summary undo

2 December 2025

• curprev 14:0114:01, 2 December 2025‎ Lucas talk contribs‎ m 18,726 bytes +90‎ Update categories. undo

4 December 2023

• curprev 13:1113:11, 4 December 2023‎ Francine talk contribs‎ 18,636 bytes +18,636‎ Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to University Cancer Center Frankfurt page '''NCTID''': NCT04821622 '''Title''': Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC '''Study Summary''': The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC. '''Sponsor''': Pfiz..."